(Q40791626)

23 September 2017

1 reference

title

Oral iron chelation: a review with special emphasis on Indian work on deferiprone (L1). (English)

1 reference

23 September 2017

0 references

M B Agarwal

1

1 reference

23 September 2017

publication date

1 July 1993

1 reference

Indian Journal of Pediatrics

23 September 2017

published in

1 reference

23 September 2017

volume

60

1 reference

23 September 2017

issue

4

1 reference

23 September 2017

page(s)

509-516

1 reference

The study of iron mobilisation from transferrin using alpha-ketohydroxy heteroaromatic chelators

23 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02751427

Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.

21 January 2018

1 reference

12 December 2020

Rarity of systemic lupus erythematosus after oral iron chelator L1

1 reference

12 December 2020

Efficacy and safety of 1-2, dimethyl-3-hydroxypyrid-4-one (L1) as an oral iron chelator in patients of beta thalassaemia major with iron overload

1 reference

12 December 2020

Studies of the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one in thalassemia patients

1 reference

12 December 2020

Long-term assessment of efficacy and safety of L1, an oral iron chelator, in transfusion dependent thalassaemia: Indian trial

1 reference

12 December 2020

The development of new iron-chelating drugs. II

1 reference

12 December 2020

New orally active iron chelators

1 reference

12 December 2020

The development of hydroxypyridin-4-ones as orally active iron chelators

1 reference

12 December 2020

Fatal systemic lupus erythematosus in patient taking oral iron chelator L1

1 reference

12 December 2020

Prospects for effective oral iron chelation therapy in man with 1,2-dimethyl-3-hydroxypyrid-4-one and other alpha-ketohydroxypyridines

1 reference

12 December 2020

Agranulocytosis and thrombocytopenia in patient with Blackfan-Diamond anaemia during oral chelator trial

1 reference

12 December 2020

L1 (1,2-dimethyl-3-hydroxypyrid-4-one) for oral iron chelation in patients with beta-thalassaemia major

1 reference

12 December 2020

Relationship between the pharmacokinetics and iron excretion pharmacodynamics of the new oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one in patients with thalassemia

1 reference

12 December 2020

Long-term trial with the oral iron chelator 1, 2-dimethyl-3-hydroxypyrid-4-one (L1). I. Iron chelation and metabolic studies

1 reference

12 December 2020

Safety of oral iron chelator L1.

1 reference

12 December 2020

Anti-nuclear antibody positivity in multi-transfused thalassemia major

1 reference

12 December 2020

Pharmacokinetic studies in humans with the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one

1 reference

12 December 2020

Long-term trial with the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1). II. Clinical observations

1 reference

12 December 2020

1,2-Dimethyl-3-hydroxypyrid-4-one, an orally active chelator for treatment of iron overload

1 reference

12 December 2020

Advances in oral iron chelation in man

1 reference

12 December 2020

Oral iron chelation with L1

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02751427

1 reference

23 September 2017

1 reference